{
  "docId": "019dd923-605c-759f-b6b3-8249779ff12a",
  "docSlug": "bi-b9ee0ec18d1bb159",
  "documentTitle": "Pitch deck: SparingVision raises $75 million for CRISPR eye treatments",
  "authorId": "Pitchdecks",
  "authorName": "SparingVision",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.779,
  "pageNumber": 10,
  "pageCount": 20,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a biological process diagram to illustrate the mechanism of action.",
  "elementsJson": [
    "headline_text",
    "action_title",
    "callout_box",
    "infographic",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-605c-759f-b6b3-8249779ff12a/10",
  "deckHref": "/decks/019dd923-605c-759f-b6b3-8249779ff12a",
  "deckJsonHref": "/decks/019dd923-605c-759f-b6b3-8249779ff12a.json",
  "deckAnchorHref": "/decks/019dd923-605c-759f-b6b3-8249779ff12a#slide-10",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "RdCVFL protective activity relies on RdCVF activity, which increases glucose entry in cones and enhances the ability of RdCVFL to repair the damage of free radical species.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-c5b1-7611-ab40-07fd70ca9819",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.9,
        "w": 0.45,
        "x": 0.512,
        "y": 0.12
      },
      "kind": "image",
      "text": "Biological mechanism diagram showing healthy retina, retinitis pigmentosa, and treatment effect",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d228bf8c-d4d8-4c56-ac1e-c4ef22d05f95",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.19,
        "w": 0.355,
        "x": 0.138,
        "y": 0.58
      },
      "kind": "paragraph",
      "text": "RdCVFL protective activity relies on RdCVF activity, which increases glucose entry in cones and enhances the ability of RdCVFL to repair the damage of free radical species",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7d7a5ee-9c84-4ec3-be94-bdfd530f0674",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.525,
        "y": 0.875
      },
      "kind": "source-note",
      "text": "1. Byrne LC, et al. J Clin Invest. 2015;125(1):105-116\n2. Mei et al. Redox Signal. 2016, 24, 909-923.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59238c1f-84f9-4cfe-8f8d-082a209f95d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.395,
        "w": 0.475,
        "x": 0.078,
        "y": 0.148
      },
      "kind": "title",
      "text": "SPVN06: RdCVF/L synergize to protect photoreceptors",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2894d4d6-5a15-4014-b8c5-f36e558a90b4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 8,
      "beatId": "e18a5479-c875-4399-9a50-63b912470a6c",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Suite of mutation-agnostic gene therapies",
      "position": 1,
      "confidence": 0.9,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "2bcb6f41-dd6b-4c6b-b90b-278201718862",
      "evidence": "Limited current treatments",
      "position": 0,
      "objective": "Highlight the need for a solution",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.8,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}